Coronavirus vaccine trials could soon begin on newborn babies and pregnant women, according to reports. Vaccine maker Janssen, part of pharmaceutical giant Johnson and Johnson, is looking to test the efficacy of the jabs on younger and younger children.
Expectant mothers are also reportedly on the company's radar. Head of viral vaccines at the firm, Hanneke Schuitemaker, said talks into approving studies into the vaccine's effects will likely include babies "at a certain point if all goes well".
It comes as researchers for Oxford-AstraZeneca will start tests on children as young as six later this month as experts continue to push to understand immune responses in all ages.